 | | TIK | | Name: | dimethyl benzene-1,2-dicarboxylate | | Formula: | C10 H10 O4 | | SMILES: | COC(=O)c1ccccc1C(=O)OC | | InChi: | InChI=1S/C10H10O4/c1-13-9(11)7-5-3-4-6-8(7)10(12)14-2/h3-6H,1-2H3 | | Synonyms: | Dimethyl phthalate | | Definition date: | 2023-04-22 | | Last modified: | 2024-12-20 | | Release date: | 2024-12-25 | | Identifier: | dimethyl benzene-1,2-dicarboxylate |
|
 | | WDK | | Name: | 2-cyano-D-phenylalanyl-2,4-dichloro-N-[(2S)-4-{[3-(dimethylamino)propyl]amino}-1-(4-fluorophenyl)-4-oxobutan-2-yl]-D-phenylalaninamide | | Formula: | C34 H39 Cl2 F N6 O3 | | SMILES: | Clc1cc(Cl)ccc1CC(NC(=O)C(N)Cc1ccccc1C#N)C(=O)NC(Cc1ccc(F)cc1)CC(=O)NCCCN(C)C | | InChi: | InChI=1S/C34H39Cl2FN6O3/c1-43(2)15-5-14-40-32(44)20-28(16-22-8-12-27(37)13-9-22)41-34(46)31(18-24-10-11-26(35)19-29(24)36)42-33(45)30(39)17-23-6-3-4-7-25(23)21-38/h3-4,6-13,19,28,30-31H,5,14-18,20,39H2,1-2H3,(H,40,44)(H,41,46)(H,42,45)/t28-,30+,31+/m0/s1 | | Definition date: | 2023-10-02 | | Last modified: | 2024-12-20 | | Release date: | 2024-12-25 | | Identifier: | 2-cyano-D-phenylalanyl-2,4-dichloro-N-[(2S)-4-{[3-(dimethylamino)propyl]amino}-1-(4-fluorophenyl)-4-oxobutan-2-yl]-D-phenylalaninamide |
|
 | | TKU | | Name: | ~{O}1-[(2~{R})-2-ethylhexyl] ~{O}2-[(2~{S})-2-ethylhexyl] benzene-1,2-dicarboxylate | | Formula: | C24 H38 O4 | | SMILES: | CCCC[CH](CC)COC(=O)c1ccccc1C(=O)OC[CH](CC)CCCC | | InChi: | InChI=1S/C24H38O4/c1-5-9-13-19(7-3)17-27-23(25)21-15-11-12-16-22(21)24(26)28-18-20(8-4)14-10-6-2/h11-12,15-16,19-20H,5-10,13-14,17-18H2,1-4H3/t19-,20+ | | Synonyms: | Bis(2-ethylhexyl) phthalate | | Definition date: | 2023-04-26 | | Last modified: | 2024-12-20 | | Release date: | 2024-12-25 | | Identifier: | ~{O}1-[(2~{R})-2-ethylhexyl] ~{O}2-[(2~{S})-2-ethylhexyl] benzene-1,2-dicarboxylate |
|
 | | A1D6P | | Name: | 1-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-methyl-phenyl]-4-methyl-1,2,3,4-tetrazol-5-one | | Formula: | C19 H17 Cl N6 O2 | | SMILES: | CN1N=NN(C1=O)c2cccc(C)c2COc3ccn(n3)c4ccc(Cl)cc4 | | InChi: | InChI=1S/C19H17ClN6O2/c1-13-4-3-5-17(26-19(27)24(2)22-23-26)16(13)12-28-18-10-11-25(21-18)15-8-6-14(20)7-9-15/h3-11H,12H2,1-2H3 | | Synonyms: | Metyltetraprole | | Definition date: | 2024-03-08 | | Last modified: | 2024-12-20 | | Release date: | 2024-12-25 | | Identifier: | 1-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-methyl-phenyl]-4-methyl-1,2,3,4-tetrazol-5-one |
|
 | | A1IAZ | | Name: | 2-[5-(1,3-benzodioxol-5-yl)-2-~{tert}-butyl-1~{H}-imidazol-4-yl]-6-methyl-pyridine | | Formula: | C20 H21 N3 O2 | | SMILES: | Cc1cccc(n1)c2nc([nH]c2c3ccc4OCOc4c3)C(C)(C)C | | InChi: | InChI=1S/C20H21N3O2/c1-12-6-5-7-14(21-12)18-17(22-19(23-18)20(2,3)4)13-8-9-15-16(10-13)25-11-24-15/h5-10H,11H2,1-4H3,(H,22,23) | | Definition date: | 2024-05-09 | | Last modified: | 2024-12-20 | | Release date: | 2024-12-25 | | Identifier: | 2-[5-(1,3-benzodioxol-5-yl)-2-~{tert}-butyl-1~{H}-imidazol-4-yl]-6-methyl-pyridine |
|
 | | A1LUV | | Name: | (5S)-5-HYDROXY-LYSINE | | Formula: | C6 H15 N2 O3 | | SMILES: | N[CH](CC[CH](O)C[NH3+])C(O)=O | | InChi: | InChI=1S/C6H14N2O3/c7-3-4(9)1-2-5(8)6(10)11/h4-5,9H,1-3,7-8H2,(H,10,11)/p+1/t4-,5-/m0/s1 | | Synonyms: | [5-azanyl-2,6-bis(oxidanyl)-6-oxidanylidene-hexyl]azanium | | Definition date: | 2024-01-22 | | Last modified: | 2024-12-20 | | Release date: | 2024-12-25 | | Identifier: | [5-azanyl-2,6-bis(oxidanyl)-6-oxidanylidene-hexyl]azanium |
|
 | | A1LVP | | Name: | 1,6-dimethyl-7-(2-oxidanyl-6-oxidanylidene-cyclohexen-1-yl)carbonyl-4-prop-2-enyl-3~{H}-1,4-benzodiazepine-2,5-dione | | Formula: | C21 H22 N2 O5 | | SMILES: | CN1C(=O)CN(CC=C)C(=O)c2c(C)c(ccc12)C(=O)C3=C(O)CCCC3=O | | InChi: | InChI=1S/C21H22N2O5/c1-4-10-23-11-17(26)22(3)14-9-8-13(12(2)18(14)21(23)28)20(27)19-15(24)6-5-7-16(19)25/h4,8-9,24H,1,5-7,10-11H2,2-3H3 | | Definition date: | 2023-12-27 | | Last modified: | 2024-12-20 | | Release date: | 2024-12-25 | | Identifier: | 1,6-dimethyl-7-(2-oxidanyl-6-oxidanylidene-cyclohexen-1-yl)carbonyl-4-prop-2-enyl-3~{H}-1,4-benzodiazepine-2,5-dione |
|
 | | EJJ | | Name: | N-CARBAMOYL-GLYCINE | | Formula: | C3 H6 N2 O3 | | SMILES: | NC(=O)NCC(O)=O | | InChi: | InChI=1S/C3H6N2O3/c4-3(8)5-1-2(6)7/h1H2,(H,6,7)(H3,4,5,8) | | Synonyms: | 2-(aminocarbonylamino)ethanoic acid | | Definition date: | 2024-01-22 | | Last modified: | 2024-12-20 | | Release date: | 2024-12-25 | | Identifier: | 2-(aminocarbonylamino)ethanoic acid |
|
 | | I7L | | Name: | 2-naphthalen-2-ylethanoic acid | | Formula: | C12 H10 O2 | | SMILES: | O=C(O)Cc1ccc2ccccc2c1 | | InChi: | InChI=1S/C12H10O2/c13-12(14)8-9-5-6-10-3-1-2-4-11(10)7-9/h1-7H,8H2,(H,13,14) | | Definition date: | 2022-02-17 | | Last modified: | 2024-12-20 | | Release date: | 2022-06-29 | | Identifier: | (naphthalen-2-yl)acetic acid |
|
 | | 8IF | | Name: | (Z,2R,4S)-1-(4-methoxy-5-methylidene-2-oxidanylidene-furan-3-yl)-2,4-dimethyl-dodec-6-ene-1,5-dione | | Formula: | C20 H28 O5 | | SMILES: | CCCCCC=CC(=O)[CH](C)C[CH](C)C(=O)C1=C(OC)C(=C)OC1=O | | InChi: | InChI=1S/C20H28O5/c1-6-7-8-9-10-11-16(21)13(2)12-14(3)18(22)17-19(24-5)15(4)25-20(17)23/h10-11,13-14H,4,6-9,12H2,1-3,5H3/t13-,14+/m0/s1 | | Definition date: | 2021-10-19 | | Last modified: | 2024-12-19 | | Release date: | 2022-11-16 | | Identifier: | (~{Z},2~{R},4~{S})-1-(4-methoxy-5-methylidene-2-oxidanylidene-furan-3-yl)-2,4-dimethyl-dodec-6-ene-1,5-dione |
|
 | | QNG | | Name: | Lenacapavir | | Formula: | C39 H32 Cl F10 N7 O5 S2 | | SMILES: | C(Cc1cc(F)cc(c1)F)(c2nc(ccc2c3ccc(c4c3n(CC(F)(F)F)nc4NS(C)(=O)=O)Cl)C#CC(S(C)(=O)=O)(C)C)NC(=O)Cn5c6c(c(n5)C(F)(F)F)C7C(C6(F)F)C7 | | InChi: | InChI=1S/C39H32ClF10N7O5S2/c1-36(2,63(3,59)60)10-9-21-5-6-22(23-7-8-26(40)30-32(23)57(17-37(43,44)45)54-35(30)55-64(4,61)62)31(51-21)27(13-18-11-19(41)14-20(42)12-18)52-28(58)16-56-34-29(33(53-56)39(48,49)50)24-15-25(24)38(34,46)47/h5-8,11-12,14,24-25,27H,13,15-17H2,1-4H3,(H,52,58)(H,54,55)/t24-,25+,27-/m0/s1 | | Synonyms: | Sunlenca | | Definition date: | 2019-11-25 | | Last modified: | 2024-12-18 | | Release date: | 2020-07-01 | | Identifier: | N-[(1S)-1-(3-{4-chloro-3-[(methylsulfonyl)amino]-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl}-6-[3-methyl-3-(methylsulfonyl)but-1-yn-1-yl]pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl]-2-[(3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl]acetamide |
|
 | | WFP | | Name: | 3,5-difluoro-L-phenylalanine | | Formula: | C9 H9 F2 N O2 | | SMILES: | N[CH](Cc1cc(F)cc(F)c1)C(O)=O | | InChi: | InChI=1S/C9H9F2NO2/c10-6-1-5(2-7(11)4-6)3-8(12)9(13)14/h1-2,4,8H,3,12H2,(H,13,14)/t8-/m0/s1 | | Definition date: | 2009-12-13 | | Last modified: | 2024-12-18 | | Identifier: | (2S)-2-azanyl-3-(3,5-difluorophenyl)propanoic acid |
|
 | | XQW | | Name: | 4-[4-(3-{2-[(5-methyl-2H-tetrazol-2-yl)methyl]-4-(trifluoromethyl)phenyl}propanoyl)piperazine-1-sulfonyl]benzene-1-sulfonamide | | Formula: | C23 H26 F3 N7 O5 S2 | | SMILES: | NS(=O)(=O)c1ccc(cc1)S(=O)(=O)N1CCN(CC1)C(=O)CCc1ccc(cc1Cn1nc(C)nn1)C(F)(F)F | | InChi: | InChI=1S/C23H26F3N7O5S2/c1-16-28-30-33(29-16)15-18-14-19(23(24,25)26)4-2-17(18)3-9-22(34)31-10-12-32(13-11-31)40(37,38)21-7-5-20(6-8-21)39(27,35)36/h2,4-8,14H,3,9-13,15H2,1H3,(H2,27,35,36) | | Definition date: | 2023-06-08 | | Last modified: | 2024-12-13 | | Release date: | 2024-12-18 | | Identifier: | 4-[4-(3-{2-[(5-methyl-2H-tetrazol-2-yl)methyl]-4-(trifluoromethyl)phenyl}propanoyl)piperazine-1-sulfonyl]benzene-1-sulfonamide |
|
 | | XR0 | | Name: | 3-fluoro-4-{[4-(3-{2-[(5-methyl-2H-tetrazol-2-yl)methyl]-4-(trifluoromethyl)phenyl}propanoyl)piperazin-1-yl]methyl}benzene-1-sulfonamide | | Formula: | C24 H27 F4 N7 O3 S | | SMILES: | NS(=O)(=O)c1ccc(CN2CCN(CC2)C(=O)CCc2ccc(cc2Cn2nc(C)nn2)C(F)(F)F)c(F)c1 | | InChi: | InChI=1S/C24H27F4N7O3S/c1-16-30-32-35(31-16)15-19-12-20(24(26,27)28)5-2-17(19)4-7-23(36)34-10-8-33(9-11-34)14-18-3-6-21(13-22(18)25)39(29,37)38/h2-3,5-6,12-13H,4,7-11,14-15H2,1H3,(H2,29,37,38) | | Definition date: | 2023-06-08 | | Last modified: | 2024-12-13 | | Release date: | 2024-12-18 | | Identifier: | 3-fluoro-4-{[4-(3-{2-[(5-methyl-2H-tetrazol-2-yl)methyl]-4-(trifluoromethyl)phenyl}propanoyl)piperazin-1-yl]methyl}benzene-1-sulfonamide |
|
 | | Y4N | | Name: | N-[(3,4-dichlorophenyl)methyl]-2-{4-oxo-6-[4-(4-sulfamoylbutanoyl)piperazin-1-yl]quinazolin-3(4H)-yl}acetamide | | Formula: | C25 H28 Cl2 N6 O5 S | | SMILES: | O=C(CCCS(N)(=O)=O)N1CCN(CC1)c1cc2C(=O)N(CC(=O)NCc3ccc(Cl)c(Cl)c3)C=Nc2cc1 | | InChi: | InChI=1S/C25H28Cl2N6O5S/c26-20-5-3-17(12-21(20)27)14-29-23(34)15-33-16-30-22-6-4-18(13-19(22)25(33)36)31-7-9-32(10-8-31)24(35)2-1-11-39(28,37)38/h3-6,12-13,16H,1-2,7-11,14-15H2,(H,29,34)(H2,28,37,38) | | Definition date: | 2023-06-11 | | Last modified: | 2024-12-13 | | Release date: | 2024-12-18 | | Identifier: | N-[(3,4-dichlorophenyl)methyl]-2-{4-oxo-6-[4-(4-sulfamoylbutanoyl)piperazin-1-yl]quinazolin-3(4H)-yl}acetamide |
|
 | | Y4R | | Name: | 2-[(2-tert-butyl-4-cyano-5-methylphenoxy)methyl]-5-(pyrrolidin-1-yl)-1,3-oxazole-4-carbonitrile | | Formula: | C21 H24 N4 O2 | | SMILES: | CC(C)(C)c1cc(C#N)c(C)cc1OCc1nc(C#N)c(o1)N1CCCC1 | | InChi: | InChI=1S/C21H24N4O2/c1-14-9-18(16(21(2,3)4)10-15(14)11-22)26-13-19-24-17(12-23)20(27-19)25-7-5-6-8-25/h9-10H,5-8,13H2,1-4H3 | | Definition date: | 2023-06-11 | | Last modified: | 2024-12-13 | | Release date: | 2024-12-18 | | Identifier: | 2-[(2-tert-butyl-4-cyano-5-methylphenoxy)methyl]-5-(pyrrolidin-1-yl)-1,3-oxazole-4-carbonitrile |
|
 | | XR6 | | Name: | (2E)-N-methyl-3-{2-[(5-methyl-2H-tetrazol-2-yl)methyl]-4-(trifluoromethyl)phenyl}-N-(2-phenoxyethyl)prop-2-enamide | | Formula: | C22 H22 F3 N5 O2 | | SMILES: | FC(F)(F)c1cc(Cn2nc(C)nn2)c(cc1)/C=C/C(=O)N(C)CCOc1ccccc1 | | InChi: | InChI=1S/C22H22F3N5O2/c1-16-26-28-30(27-16)15-18-14-19(22(23,24)25)10-8-17(18)9-11-21(31)29(2)12-13-32-20-6-4-3-5-7-20/h3-11,14H,12-13,15H2,1-2H3 | | Definition date: | 2023-06-08 | | Last modified: | 2024-12-13 | | Release date: | 2024-12-18 | | Identifier: | (2E)-N-methyl-3-{2-[(5-methyl-2H-tetrazol-2-yl)methyl]-4-(trifluoromethyl)phenyl}-N-(2-phenoxyethyl)prop-2-enamide |
|
 | | Y4W | | Name: | 1-[4-({7-[(3,4-difluorophenyl)methyl]-9-methyl-8-oxo-8,9-dihydro-7H-purin-2-yl}amino)benzoyl]piperidine-4-sulfonamide | | Formula: | C25 H25 F2 N7 O4 S | | SMILES: | NS(=O)(=O)C1CCN(CC1)C(=O)c1ccc(cc1)Nc1ncc2c(n1)N(C)C(=O)N2Cc1ccc(F)c(F)c1 | | InChi: | InChI=1S/C25H25F2N7O4S/c1-32-22-21(34(25(32)36)14-15-2-7-19(26)20(27)12-15)13-29-24(31-22)30-17-5-3-16(4-6-17)23(35)33-10-8-18(9-11-33)39(28,37)38/h2-7,12-13,18H,8-11,14H2,1H3,(H2,28,37,38)(H,29,30,31) | | Definition date: | 2023-06-11 | | Last modified: | 2024-12-13 | | Release date: | 2024-12-18 | | Identifier: | 1-[4-({7-[(3,4-difluorophenyl)methyl]-9-methyl-8-oxo-8,9-dihydro-7H-purin-2-yl}amino)benzoyl]piperidine-4-sulfonamide |
|
 | | XRC | | Name: | 2-(3,4-dichlorophenyl)-1-{4-[(4-fluorophenyl)methyl]-7,8-dihydropyrido[4,3-d]pyrimidin-6(5H)-yl}ethan-1-one | | Formula: | C22 H18 Cl2 F N3 O | | SMILES: | Clc1ccc(cc1Cl)CC(=O)N1CCc2ncnc(Cc3ccc(F)cc3)c2C1 | | InChi: | InChI=1S/C22H18Cl2FN3O/c23-18-6-3-15(9-19(18)24)11-22(29)28-8-7-20-17(12-28)21(27-13-26-20)10-14-1-4-16(25)5-2-14/h1-6,9,13H,7-8,10-12H2 | | Definition date: | 2023-06-08 | | Last modified: | 2024-12-13 | | Release date: | 2024-12-18 | | Identifier: | 2-(3,4-dichlorophenyl)-1-{4-[(4-fluorophenyl)methyl]-7,8-dihydropyrido[4,3-d]pyrimidin-6(5H)-yl}ethan-1-one |
|
 | | Y4Z | | Name: | 10-{[3-(trifluoromethoxy)phenyl]methyl}-3,4,5,10-tetrahydroazepino[3,4-b]indole-2(1H)-carboxamide | | Formula: | C21 H20 F3 N3 O2 | | SMILES: | FC(F)(F)Oc1cccc(c1)Cn1c2ccccc2c2CCCN(Cc12)C(N)=O | | InChi: | InChI=1S/C21H20F3N3O2/c22-21(23,24)29-15-6-3-5-14(11-15)12-27-18-9-2-1-7-16(18)17-8-4-10-26(20(25)28)13-19(17)27/h1-3,5-7,9,11H,4,8,10,12-13H2,(H2,25,28) | | Definition date: | 2023-06-11 | | Last modified: | 2024-12-13 | | Release date: | 2024-12-18 | | Identifier: | 10-{[3-(trifluoromethoxy)phenyl]methyl}-3,4,5,10-tetrahydroazepino[3,4-b]indole-2(1H)-carboxamide |
|
 | | XRI | | Name: | 5-tert-butyl-2-methyl-4-({5-[(5S)-2-oxa-7-azaspiro[4.4]nonane-7-carbonyl]-1H-pyrazol-3-yl}methoxy)benzonitrile | | Formula: | C24 H30 N4 O3 | | SMILES: | CC(C)(C)c1cc(C#N)c(C)cc1OCc1cc([NH]n1)C(=O)N1CCC2(CCOC2)C1 | | InChi: | InChI=1S/C24H30N4O3/c1-16-9-21(19(23(2,3)4)10-17(16)12-25)31-13-18-11-20(27-26-18)22(29)28-7-5-24(14-28)6-8-30-15-24/h9-11H,5-8,13-15H2,1-4H3,(H,26,27)/t24-/m0/s1 | | Definition date: | 2023-06-08 | | Last modified: | 2024-12-13 | | Release date: | 2024-12-18 | | Identifier: | 5-tert-butyl-2-methyl-4-({5-[(5S)-2-oxa-7-azaspiro[4.4]nonane-7-carbonyl]-1H-pyrazol-3-yl}methoxy)benzonitrile |
|
 | | XDB | | Name: | 3-fluoro-4-({[1-(3-{2-[(5-methyl-2H-tetrazol-2-yl)methyl]-4-(trifluoromethyl)phenyl}propanoyl)piperidin-4-yl]methyl}sulfanyl)benzene-1-sulfonamide | | Formula: | C25 H28 F4 N6 O3 S2 | | SMILES: | NS(=O)(=O)c1ccc(SCC2CCN(CC2)C(=O)CCc2ccc(cc2Cn2nc(C)nn2)C(F)(F)F)c(F)c1 | | InChi: | InChI=1S/C25H28F4N6O3S2/c1-16-31-33-35(32-16)14-19-12-20(25(27,28)29)4-2-18(19)3-7-24(36)34-10-8-17(9-11-34)15-39-23-6-5-21(13-22(23)26)40(30,37)38/h2,4-6,12-13,17H,3,7-11,14-15H2,1H3,(H2,30,37,38) | | Definition date: | 2023-06-06 | | Last modified: | 2024-12-13 | | Release date: | 2024-12-18 | | Identifier: | 3-fluoro-4-({[1-(3-{2-[(5-methyl-2H-tetrazol-2-yl)methyl]-4-(trifluoromethyl)phenyl}propanoyl)piperidin-4-yl]methyl}sulfanyl)benzene-1-sulfonamide |
|
 | | XRN | | Name: | [4-(trifluoromethoxy)phenyl]methyl (3aR,6aS)-5-(4-sulfamoylpiperidine-1-carbonyl)hexahydropyrrolo[3,4-c]pyrrole-2(1H)-carboxylate | | Formula: | C21 H27 F3 N4 O6 S | | SMILES: | NS(=O)(=O)C1CCN(CC1)C(=O)N1CC2CN(CC2C1)C(=O)OCc1ccc(OC(F)(F)F)cc1 | | InChi: | InChI=1S/C21H27F3N4O6S/c22-21(23,24)34-17-3-1-14(2-4-17)13-33-20(30)28-11-15-9-27(10-16(15)12-28)19(29)26-7-5-18(6-8-26)35(25,31)32/h1-4,15-16,18H,5-13H2,(H2,25,31,32) | | Definition date: | 2023-06-08 | | Last modified: | 2024-12-13 | | Release date: | 2024-12-18 | | Identifier: | [4-(trifluoromethoxy)phenyl]methyl (3aR,6aS)-5-(4-sulfamoylpiperidine-1-carbonyl)hexahydropyrrolo[3,4-c]pyrrole-2(1H)-carboxylate |
|
 | | XRT | | Name: | 3-[3-({[(4-bromophenyl)methyl]amino}methyl)-1H-indol-1-yl]-N-methylpropanamide | | Formula: | C20 H22 Br N3 O | | SMILES: | Brc1ccc(cc1)CNCc1cn(CCC(=O)NC)c2ccccc21 | | InChi: | InChI=1S/C20H22BrN3O/c1-22-20(25)10-11-24-14-16(18-4-2-3-5-19(18)24)13-23-12-15-6-8-17(21)9-7-15/h2-9,14,23H,10-13H2,1H3,(H,22,25) | | Definition date: | 2023-06-08 | | Last modified: | 2024-12-13 | | Release date: | 2024-12-18 | | Identifier: | 3-[3-({[(4-bromophenyl)methyl]amino}methyl)-1H-indol-1-yl]-N-methylpropanamide |
|
 | | XRZ | | Name: | N-[(3-chloro-4-cyanophenyl)methyl]-2-{6-[1-(methoxyacetyl)piperidin-4-yl]-4-oxoquinazolin-3(4H)-yl}-N-methylacetamide | | Formula: | C27 H28 Cl N5 O4 | | SMILES: | O=C(COC)N1CCC(CC1)c1ccc2N=CN(CC(=O)N(C)Cc3ccc(C#N)c(Cl)c3)C(=O)c2c1 | | InChi: | InChI=1S/C27H28ClN5O4/c1-31(14-18-3-4-21(13-29)23(28)11-18)25(34)15-33-17-30-24-6-5-20(12-22(24)27(33)36)19-7-9-32(10-8-19)26(35)16-37-2/h3-6,11-12,17,19H,7-10,14-16H2,1-2H3 | | Definition date: | 2023-06-08 | | Last modified: | 2024-12-13 | | Release date: | 2024-12-18 | | Identifier: | N-[(3-chloro-4-cyanophenyl)methyl]-2-{6-[1-(methoxyacetyl)piperidin-4-yl]-4-oxoquinazolin-3(4H)-yl}-N-methylacetamide |
|
